Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine.
Decision Making, Computer-Assisted
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine.
Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine. Cancer Lett. 2011 Aug 01; 307(1):53-61.
View in:
PubMed
subject areas
Annexin A5
Antimetabolites
Aorta
Breast Neoplasms
Cell Survival
Cells, Cultured
Combined Modality Therapy
Cytosine Deaminase
Endothelium, Vascular
Female
Flucytosine
Fluorouracil
Genetic Therapy
Humans
Phosphatidylserines
Prodrugs
Recombinant Fusion Proteins
authors with profiles
Roger G Harrison